RS
ALT icon

R Squared’s Altimmune ALT Stock Holding History

R Squared’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,930
Closed -$21.1K – 339
2024
Q4 		$21.1K Buy
+2,930
New +$22.4K 0.02% 851

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

R Squared's ALT Position: Q1 2025 in Review

R Squared sold out of Altimmune (ALT) in Q1 2025, closing a stake of 2,930 shares — an estimated $21.1K sold.

R Squared first reported a position in ALT in Q4 2024 and held it in 1 quarter. The position peaked at $21.1K in Q4 2024. 176 funds tracked by Wall St. Rank hold ALT as of Q1 2025.

  • R Squared reported no remaining Altimmune position as of Q1 2025 after selling out during the quarter.
  • R Squared sold 2,930 Altimmune shares in Q1 2025, an estimated $21.1K.
  • R Squared first reported a position in Altimmune in Q4 2024 and held it in 1 quarter.
  • R Squared's Altimmune position peaked at $21.1K in Q4 2024.
  • 176 funds tracked by Wall St. Rank held Altimmune as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.